Back


02/04/2020
Dynacure Announces €50M ($55M) Series C Financing
STRASBOURG, France and PHILADELPHIA, April 2, 2020 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today the close of a €50 million Series C financing led by Perceptive Advisors. [...]

Download the pdf file





X

X